| # | Drug | Count |
|---|---|---|
| 0 | CIPROFLOXACIN | 4 |
| 1 | CIPROFLOXACIN HYDROCHLORIDE | 4 |
| 2 | CIPROFLOXACIN TABLETS | 4 |
| 3 | CIPROFOLXACIN | 4 |
| 4 | MESALAMINE | 3 |
| 5 | TACROLIMUS | 3 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 7 | TACROLIMUS OINTMENT 0.1% | 3 |
| 8 | CYTARABINE | 2 |
| 9 | DICLOFENAC | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTOXIFYLLINE | 1 | 0.0002 |
| 1 | TREMELIMUMAB | 1 | 0.0002 |
| 2 | PEGASPARGASE | 2 | 0.0002 |
| 3 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| 4 | MESALAMINE | 3 | 0.0001 |
| 5 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 6 | HUMAN IMMUNOGLOBULIN G | 2 | 0.0001 |
| 7 | CEFUROXIME | 1 | 0.0001 |
| 8 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 1 | 0.0001 |
| 9 | VINCRISTINE SULFATE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 1 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 3 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 5 | Fluoroquinolone Antibacterial [EPC] | 4 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 8 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Antirheumatic Agent [EPC] | 2 | 0.0000 |